Fabio Massimo Perrotta

Prehabilitation in rheumatology: a missing link in psoriatic disease management

Ennio Lubrano, Fabio Massimo Perrotta, Mauro Fatica, Flavia Sunzini et autres

it, gb (code pays fourni par la source)

Anifrolumab as a therapeutic option in mixed connective tissue disease with autoimmune cytopenia: a case report and narrative review of the literature

Noemi Italiano, Fabio Massimo Perrotta, Mauro Fatica, Ennio Lubrano

it (code pays fourni par la source)

Longitudinal Instability of Minimal Disease Activity Domains in Psoriatic Arthritis with Fluctuating Response: A Trajectory Analysis of a Real-World Cohort

Mauro Fatica, Fabio Massimo Perrotta, Noemi Italiano, Eneida Çela et autres

it (code pays fourni par la source)

Does articular and entheseal structural damage drive pain and patient-driven reported outcomes in patients with difficult-to-treat psoriatic arthritis? Results from a cross-sectional study

Fabio Massimo Perrotta, Alen Zabotti, Mauro Fatica, Nicola Cabas et autres

Predicting the course: Real-world trajectories toward minimal disease activity in psoriatic arthritis

Mauro Fatica, Fabio Massimo Perrotta, P Conigliaro, Maria Sole Chimenti et autres

it (code pays fourni par la source)

Prescription Patterns in Psoriatic Arthritis: Insights from a Sex-Based Perspective

Mauro Fatica, Fabio Massimo Perrotta, Paola Conigliaro, Maria Sole Chimenti et autres

it (code pays fourni par la source)

The Efficacy of High-Flow Nasal Cannula (HFNC) Treatment in Patients with Chronic Type II Respiratory Failure Secondary to COPD

Raffaella Pagliaro, Vittorio Simeon, Luca Notizia, Stefania Arena et autres

it (code pays fourni par la source)

Ixekizumab for the treatment of psoriatic arthritis: an Italian multicentric retrospective observational study

Stefano Gentileschi, Riccardo Terribili, Carla Gaggiano, Elisa Fiorentini et autres

it (code pays fourni par la source)

Chronic obstructive pulmonary disease (COPD) and cardiovascular comorbidities: Shedding light on key interactions and therapeutic approaches

Giulia Maria Stella, F Bertuccio, Valentina Conio, Chandra Bortolotto et autres

it (code pays fourni par la source)

Comparative effectiveness and predictors of remission between adalimumab and ixekizumab in patients with psoriatic arthritis: findings from the ‘AIRE’ multicentre study

Valentino Paci, Alen Zabotti, Alessandro Fontanarosa, Eleonora Celletti et autres

it (code pays fourni par la source)

Navigating the Journey in Psoriatic Arthritis: Matching the Right Patient, the Right Drug, and the Right Time

Ennio Lubrano, Mauro Fatica, Noemi Italiano, Fabio Massimo Perrotta

it (code pays fourni par la source)

The concept of severity in psoriatic arthritis: a scoping review of the literature

Ennio Lubrano, Mauro Fatica, Rubén Queiró, Fabio Massimo Perrotta

it, es (code pays fourni par la source)